TITLE

New Guideline for Treatment of Dementia

PUB. DATE
June 2008
SOURCE
Critical Care Nurse;Jun2008, Vol. 28 Issue 3, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the new guideline for treating dementia released by the American College of Physicians and the American Academy of Family Physicians in the U.S. The guideline is based on a review of the efficacy of dementia medications, such as cholinesterase, galantamine and rivastigmine, approved by the Food and Drug Administration (FDA).
ACCESSION #
32682750

 

Related Articles

  • Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians. Qaseem, Amir; Snow, Vincenza; Cross Jr., J. Thomas; Forciea, Mary Ann; Hopkins Jr., Robert; Shekelle, Paul; Adelman, Alan; Mehr, David; Schellhase, Kenneth; Campos-Outcalt, Doug; Santaguida, Pasqualina; Owens, Douglas K. // Annals of Internal Medicine;3/4/2008, Vol. 148 Issue 5, p370 

    Description: The American College of Physicians and American Academy of Family Physicians developed this guideline to present the available evidence on current pharmacologic treatment of dementia. Methods: The targeted literature search included evidence related to the effectiveness of 5 U.S....

  • aafp NEWS NOW.  // American Family Physician;4/1/2011, Vol. 83 Issue 7, p793 

    The article offers news briefs concerning the American Academy of Family Physicians (AAFP). A joint statement was released by AAFP and American Academy of Physician Assistants (AAPA) on the role of physician assistants (PAs) in a team-oriented practice model. The importance of a healthy diet and...

  • Varicella vaccine approved by FDA.  // American Family Physician;5/1/1995, Vol. 51 Issue 6, p1611 

    Reports on the approval of the varicella virus vaccine (Varivax) by the United States Food and Drug Administration, for the prevention of chicken pox. Recommended dose for children; Results of clinical trials; Postmarketing studies planned by Varivax manufacturer; Recommendation of the American...

  • KEY ABBREVIATIONS.  // Journal of Family Practice;Feb2007 Supplement, Vol. 56 Issue 2, pS73 

    A list of abbreviations related to medical care in the U.S. is presented. The list includes abbreviations for the American Academy of Family Physicians, antibody to hepatitis B surface antigen, the U.S. Food and Drug Administration, Program for Appropriate Technology in Health, and the Special...

  • AAFP says NO to Energy Drink Samples for Kids.  // Texas Journal of Chiropractic;Winter2014, Vol. 29 Issue 1, p10 

    The article reports that the American Academy of Family Physicians oppose free samples of high-energy drinks being given to children and have agreed to work with the U.S. Food and Drug Administration (FDA) for establishment of definitions of energy drinks.

  • Keep REMS ed optional: AAFP. M. I. // Medical Marketing & Media;Sep2013, Vol. 48 Issue 9, p16 

    The article reports on the call of the American Academy of Family Physicians (AAFP) to the U.S. Food and Drug Administration to make long acting opioids voluntary and extend the risk evaluation and mitigation strategy (REMS)-specific continuing medical education (CME).

  • Drug Treatment for Patients with Dementia: American College of Physicians and American Academy of Family Physicians Recommendations.  // Annals of Internal Medicine;3/4/2008, Vol. 148 Issue 5, pI41 

    The article presents the recommendations developed by the American College of Physicians and American Academy of Family Physicians in the U.S. concerning cholinesterase inhibitors and neuropeptide-modifying agents that can modestly slow the worsening of dementia in some patients. It is cited...

  • Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline. Raina, Parminder; Santaguida, Pasqualina; Ismaila, Afisi; Patterson, Christopher; Cowan, David; Levine, Mitchell; Booker, Lynda; Oremus, Mark // Annals of Internal Medicine;3/4/2008, Vol. 148 Issue 5, p379 

    Background: The effectiveness of the 5 U.S. Food and Drug Administration-approved pharmacologic therapies for dementias in achieving clinically relevant improvements is unclear. Purpose: To review the evidence for the effectiveness of cholinesterase inhibitors (donepezil, galantamine,...

  • aafp NEWS NOW.  // American Family Physician;5/15/2013, Vol. 87 Issue 10, following p2 

    This section offers news briefs related to the health sector in the U.S. It relates the response of the American Academy of Family Physicians (AAFP) to a draft proposal from the U.S. House aimed at eliminating the sustainable growth rate (SGR) formula and at reforming Medicare. The updated...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics